Novartis AG (NVS)
158.00
-0.86
(-0.54%)
USD |
NYSE |
Aug 24, 16:00
158.00
0.00 (0.00%)
After-Hours: 20:00
Novartis Total Assets (Quarterly) : 122.03B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.03B |
| March 31, 2026 | 118.53B |
| December 31, 2025 | 115.57B |
| September 30, 2025 | 107.29B |
| June 30, 2025 | 104.39B |
| March 31, 2025 | 99.94B |
| December 31, 2024 | 106.76B |
| September 30, 2024 | 103.52B |
| June 30, 2024 | 97.50B |
| March 31, 2024 | 94.33B |
| December 31, 2023 | 103.82B |
| September 30, 2023 | 112.70B |
| June 30, 2023 | 110.98B |
| March 31, 2023 | 112.24B |
| December 31, 2022 | 121.77B |
| September 30, 2022 | 118.46B |
| June 30, 2022 | 122.91B |
| March 31, 2022 | 125.22B |
| December 31, 2021 | 135.88B |
| September 30, 2021 | 121.21B |
| June 30, 2021 | 124.02B |
| March 31, 2021 | 121.75B |
| December 31, 2020 | 132.19B |
| September 30, 2020 | 129.68B |
| June 30, 2020 | 123.76B |
| Date | Value |
|---|---|
| March 31, 2020 | 123.10B |
| December 31, 2019 | 118.41B |
| September 30, 2019 | 115.97B |
| June 30, 2019 | 116.29B |
| March 31, 2019 | 137.95B |
| December 31, 2018 | 145.65B |
| September 30, 2018 | 142.99B |
| June 30, 2018 | 142.06B |
| March 31, 2018 | 135.52B |
| December 31, 2017 | 133.23B |
| September 30, 2017 | 134.97B |
| June 30, 2017 | 133.75B |
| March 31, 2017 | 131.99B |
| December 31, 2016 | 130.39B |
| September 30, 2016 | 134.01B |
| June 30, 2016 | 131.44B |
| March 31, 2016 | 132.45B |
| December 31, 2015 | 131.90B |
| September 30, 2015 | 132.93B |
| June 30, 2015 | 135.41B |
| March 31, 2015 | 134.94B |
| December 31, 2014 | 125.77B |
| September 30, 2014 | 125.38B |
| June 30, 2014 | 125.77B |
| March 31, 2014 | 125.33B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Roche Holding AG | -- |
| AstraZeneca PLC | 114.02B |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 80.09B |
| Shareholders Equity (Quarterly) | 41.54B |
| Debt to Equity Ratio | 1.180 |
| Current Ratio | 0.8615 |
| Net Debt Paydown Yield | -1.24% |